Program death ligand‐1 immunocytochemistry in lung cancer cytological samples: A systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24955
Abstract: In this era of personalized medicine, targeted immunotherapies like immune checkpoint inhibitors (ICI) blocking the programmed death‐1 (PD‐1)/program death ligand‐1 (PD‐L1) axis have become an integral part of treating advanced stage non‐small cell lung carcinoma… read more here.
Keywords: death ligand; lung; program death; cytology ... See more keywords